Vaccine-Preventable Diseases

Top Story

FDA approves Flucelvax Quadrivalent

May 24, 2016

The FDA recently approved Flucelvax Quadrivalent — the first seasonal influenza vaccine to be cell-derived and to protect against the four major strains of influenza A and B — for patients aged 4 years and older, according to its manufacturer.

“Flucelvax Quadrivalent will provide health care providers and their patients with an important option to further broaden their influenza coverage,” Gordon Naylor, president of Seqirus, said in a press release. “We are pleased to offer Flucelvax Quadrivalent … to our valued customers during the 2016-2017 flu season.”

HIV Vaccine Awareness Day: Research continues for effective preventive, therapeutic vaccines

May 18, 2016
National HIV Vaccine Awareness Day is observed annually on May 18 to mark the progress made in developing an effective HIV vaccine, to acknowledge those who have…
In the Journals

Uniformity in male HPV vaccinations encouraged in Canada

May 18, 2016
A recent Canadian analysis published in CMAJ reported that male vaccination programs are necessary in order to ensure equality in protection from HPV-associated diseases…

Ongoing varicella outbreak affects 75 children in New York

May 17, 2016
The New York City Department of Health and Mental Hygiene recently issued an advisory to physicians concerning an ongoing investigation into 75 cases of varicella in the…

Childhood Immunization Policies and the Prevention of Communicable Disease

Pediatric Annals, March 2011, Volume 40 Issue 3
1. Review the process through which vaccines are licensed and recommendations are developed for routine use. 2. Discuss…
More »

Immunization Updates 2015: Pediatrics & Adolescents

This activity is supported by an educational grant from Merck & Co. Inc.

Despite the proven remarkable effectiveness of vaccines and the striking global impact of immunization campaigns in…
More »
PAS 2016

PAS 2016

Meeting News Coverage

VIDEO: New approaches needed to address vaccine resistance

April 19, 2016
More »

‘Pox parties’ still pose risk for severe chickenpox complications

January 8, 2016
Despite the role that vaccines play in drastically reducing the incidence of varicella cases since the vaccination became available in 1995…

In the Journals

Strong recommendations for HPV vaccine lacking among pediatricians, family practitioners

January 5, 2016
Nearly one-third of physicians reported not strongly recommending HPV vaccination at patients’ 11-12 year well visit, and they were even less…

In the Journals

BCG vaccine demonstrates long-lasting effectiveness

December 28, 2015
Recent data showed the bacille Calmette-Guérin vaccine reduced the risk for tuberculosis after 40 years of vaccination, suggesting the vaccine…

WHO agrees to review Merck’s Ebola vaccine for emergency use

December 23, 2015
Merck announced that the application for Emergency Use Assessment and Listing for its investigational Ebola vaccine has been accepted by WHO for…

In the Journals

Influenza vaccine effectively treats obese children

December 23, 2015
Influenza vaccine was effective among a cohort of obese children, a population that tends to have longer duration of illness when infected, according…


Infants infected with vaccine-derived polio in Myanmar

December 22, 2015
Two children have contracted circulating vaccine-derived poliovirus type 2 with accompanying acute flaccid paralysis in Myanmar, according to…

In the Journals

Vaccine coverage among teens with chronic health conditions above average

December 18, 2015
Vaccine coverage among adolescents with chronic health conditions was greater than that of healthy adolescents, highlighting important gaps in…

In the Journals

Incentives improve rabies vaccination coverage

December 17, 2015
Recent findings published in PLoS Neglected Tropical Diseases showed that brightly colored dog collars and owner wristbands, which distinguished…

FDA News

FDA expands Gardasil 9 HPV vaccine approval to boys, young men

December 16, 2015
The FDA expanded the age indication for Gardasil 9 HPV vaccine to include boys and men aged 16 to 26 years, according to a press release from Merck…

Meeting News Coverage

Investigational hexavalent vaccine safe, effective when given with RotaTeq, Prevnar 13

Infectious Diseases in Children, December 2015
An investigational combination hexavalent vaccine for protection against diphtheria, tetanus, pertussis, poliovirus, Haemophilus influenzae type b…

More Headlines »